- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Autoimmune Pancreatitis Type 2 in Poland
Total 838 results
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusBrazil, Canada, Mexico, India, Australia, China, Korea, Republic of
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Argentina, Brazil, Canada, Chile, Colombia, Czech Republic, Denmark, Estonia, France, Germany, Hungary, India, Israel, Italy, Malaysia, Mexico, Netherlands, Poland, Puerto Rico, Romania, Russian Federation, South Africa, Swed... and more
-
Ionis Pharmaceuticals, Inc.CompletedType 2 Diabetes MellitusPoland, Romania, Russian Federation
-
PfizerCompletedHealthy | Type 2 Diabetes MellitusUnited States
-
vTv TherapeuticsCompletedType 2 Diabetes MellitusUnited States
-
TheracosCompletedType 2 Diabetes MellitusUnited States, Canada
-
Tandem Diabetes Care, Inc.Jaeb Center for Health ResearchActive, not recruitingType 2 Diabetes Treated With InsulinUnited States, Canada
-
Valeritas, Inc.Integrated Medical DevelopmentCompletedType 2 Diabetes MellitusUnited States
-
SanofiCompletedType 2 Diabetes MellitusEstonia, Italy, Israel, United States, Canada, Germany, Romania, Slovakia, Spain
-
Regeneron PharmaceuticalsBayerActive, not recruitingType 2 Diabetes Mellitus | Diabetic Macular Edema | Type 1 Diabetes MellitusUnited States, Puerto Rico, Japan, United Kingdom, Canada, Czechia, Germany, Hungary
-
Technical University of MunichUniversitaire Ziekenhuizen KU Leuven; Helmholtz Zentrum München; Medical University... and other collaboratorsActive, not recruitingDiabetes Mellitus, Type 1Belgium, Germany, Poland, Sweden, United Kingdom
-
Ionis Pharmaceuticals, Inc.CompletedHepatic SteatosisCanada, Hungary, Poland, United Kingdom
-
Gilead SciencesCompletedType 2 Diabetes MellitusUnited States, Russian Federation, Israel, South Africa, India, Hungary, Ukraine, Canada, Czech Republic, Mexico, Poland
-
ConjuChemTerminatedType 2 Diabetes Mellitus (T2DM)United States, Canada
-
Novo Nordisk A/SCompletedHealthy | Diabetes Mellitus, Type 2 | DiabetesPoland, Slovakia, Czechia
-
PfizerCompletedType 2 Diabetes MellitusUnited States, Canada
-
TheracosCompletedType 2 Diabetes MellitusUnited States, Canada, Czechia, Denmark, Korea, Republic of, Mexico, Netherlands, Poland, Russian Federation, Taiwan
-
AstraZenecaCompletedType 2 Diabetes MellitusUnited States
-
Fractyl Health Inc.RecruitingType 2 DiabetesUnited States, Ireland, United Kingdom, Belgium, Italy, Netherlands, Switzerland, Spain, France
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus | Diabetes Mellitus, Type 1Israel, United Kingdom, France, Netherlands, Spain, Finland, Malaysia, Norway, Italy, Germany, Poland, Romania, Portugal, Ireland, Croatia, Greece
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Czechia, Puerto Rico, Poland, Mexico
-
Medtronic DiabetesRecruitingType 2 Diabetes Treated With InsulinUnited States
-
Astellas Pharma IncCompletedType 2 Diabetes MellitusUnited States, Hungary, Poland, Romania, Italy, United Kingdom
-
National Institute of Diabetes and Digestive and...George Washington UniversityCompletedType 2 DiabetesUnited States
-
MetaCure (USA), Inc.CompletedDiabetes Mellitus, Type 2Austria, Germany, Italy, Poland
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesUnited States, Germany, Poland, Argentina, United Kingdom, Mexico
-
vTv TherapeuticsCompletedType 2 Diabetes MellitusUnited States
-
Legacy Health SystemJuvenile Diabetes Research FoundationCompleted
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2France, Poland, United Kingdom, United States, Spain, Colombia, India, Romania, South Africa, Ukraine, Australia, Canada, Greece, Sweden, New Zealand, Switzerland, Hong Kong
-
TheracosCompletedDiabetes MellitusUnited States
-
University of ChicagoNational Institute on Minority Health and Health Disparities (NIMHD); Advocate... and other collaboratorsRecruitingStroke | Hypertension | Obesity | Peripheral Vascular Diseases | Hyperlipidemias | T2DM (Type 2 Diabetes Mellitus) | Heart Disease ChronicUnited States
-
Oregon Health and Science UniversityCompleted
-
Legacy Health SystemJuvenile Diabetes Research FoundationCompletedType 1 Diabetes MellitusUnited States
-
Novartis PharmaceuticalsCompletedType 2 Diabetes MellitusCanada, United States, Italy, Poland, Puerto Rico
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusCzech Republic, Italy, Poland, Spain, United Kingdom, Germany, Hungary, Finland, Mexico, Austria, France, Israel, Switzerland, Ireland
-
NovartisCompletedType 2 Diabetes MellitusRussian Federation, Germany, United States
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusAustralia, France, Italy, Korea, Republic of, Mexico, Spain, Poland, Romania, South Africa, Argentina, Austria, Belgium, Germany, Hungary, Israel, Slovakia, Greece, India, Taiwan, Canada, Czech Republic
-
Oregon Health and Science UniversityThe Leona M. and Harry B. Helmsley Charitable TrustCompleted
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States
-
Oregon Health and Science UniversityCompletedPrimary Health Care | Type II Diabetes | Behavioral HealthUnited States
-
Oregon Health and Science UniversityCompleted
-
Oregon Health and Science UniversityCompleted
-
InteKrin Therapeutics, Inc.CompletedType 2 Diabetes MellitusUnited States, Mexico
-
Tranzyme, Inc.CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | GastroparesisUnited States, Belgium, Denmark, Finland, Germany, Norway, Poland, Sweden
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Croatia, Poland, Romania, South Africa, Turkey
-
AstraZenecaCompleted
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Mexico, India
-
AstraZenecaJuvenile Diabetes Research FoundationCompletedType 1 DiabetesUnited States
-
AstraZenecaCompletedType 2 Diabetes Mellitus | Inadequate Glycaemic ControlUnited States, Canada, Czechia, Germany, Russian Federation, Mexico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesPoland